First MPox case confirmed in Kerala

Efficacy of Mpox Vaccine Wanes Within a Year, Studies Reveal

The escalating global Mpox outbreak has been met with a concerning revelation. Two distinct studies have indicated that the efficacy of Bavarian Nordic's vaccine, known as Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), appears to diminish to undetectable levels within a span of 6 to 12 months. Sep 22, 2024
Mysterious fever worsens in Kutch amid heavy rain, toll touches 15

Mysterious Fever Claims over 15 lives in Rain-Stricken Kutch

The Kutch district is struggling with a mysterious fever that has claimed over 15 lives, predominantly in the Lakhpat taluka. The situation has been exacerbated by the recent heavy rains, which have led to a surge in the number of cases. The cause of the fever remains unknown, leading to heightened concern among the authorities and the local population. Sep 11, 2024
New Mpox strain poses a notable risk to children: Experts

Mpox Cases Continue at Low Levels, Vaccination Efforts Intensify

The global outbreak of Clade II mpox, primarily spread through intimate contact, continues with a survival rate of over 99%. The CDC suggests that two doses of the mpox vaccine can prevent the disease, and the antiviral drug TPOXX is being tested for treatment. Sep 9, 2024
New Mpox strain poses a notable risk to children: Experts

CDC Study Eases Fears of Airborne Mpox Transmission

The CDC reports that the monkeypox virus (MPXV) is less airborne than Covid-19, based on a study involving 113 individuals with mpox. The WHO emphasizes the need for international cooperation and swift action in response to the mpox outbreak and other emerging infectious diseases. Sep 8, 2024